跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salbucass - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salbucass
Approved
STANDARD
Salbucass
Azarias Pharmaceutical Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1efbf81bfd05e5c9
Company
Azarias Pharmaceutical Laboratories Inc
Type
Standard
Approval Details
Approval Id
1efbf81bfd05e5c9
Drug Approval Philippines Name
Salbucass
Product Name
Salbucass
Registration Number
DRP-4476-02
Brand Name
Salbucass
Generic Name
Salbutamol (as sulfate) + Guaifenesin
Dosage Form
Capsule
Dosage Strength
2 mg/100 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc
Distributor
Cassandras Care Pharmaceutical Distributor
Issuance Date
26 November 2023
Expiry Date
13 June 2028
Pharmacologic Category
Antiasthma/Expectorant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1efbf81bfd05e5c9
Type
Standard
Back to Philippines FDA Approvals